Recommendations on the management of pulmonary hypertension in clinical practice.
D000328:Adult; D000553:Ambulatory Care / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use; D002120:Calcium Channel Agonists / Q000627:therapeutic use; D002648:Child; D003240:Connective Tissue Diseases / Q000150:complications; D006330:Heart Defects, Congenital / Q000150:complications; D006391:Hemangioma / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D008175:Lung Neoplasms / Q000150:complications; D016040:Lung Transplantation / Q000379:methods; D010100:Oxygen / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D012017:Referral and Consultation; D012944:Social Support; D017131:Thrombectomy / Q000379:methods; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D002120:Calcium Channel Agonists; D011453:Prostaglandins; D014665:Vasodilator Agents; D010100:Oxygen